APA (7th ed.) Citation

Xiaoxia Yang, Pengfei Shang, Bingfang Yu, Qiuyang Jin, Jing Liao, Lei Wang, . . . Xiuli Guo. (2021). Combination therapy with miR34a and doxorubicin synergistically inhibits Dox-resistant breast cancer progression via down-regulation of Snail through suppressing Notch/NF-κB and RAS/RAF/MEK/ERK signaling pathway. Elsevier.

Chicago Style (17th ed.) Citation

Xiaoxia Yang, Pengfei Shang, Bingfang Yu, Qiuyang Jin, Jing Liao, Lei Wang, Jianbo Ji, and Xiuli Guo. Combination Therapy with MiR34a and Doxorubicin Synergistically Inhibits Dox-resistant Breast Cancer Progression via Down-regulation of Snail Through Suppressing Notch/NF-κB and RAS/RAF/MEK/ERK Signaling Pathway. Elsevier, 2021.

MLA (9th ed.) Citation

Xiaoxia Yang, et al. Combination Therapy with MiR34a and Doxorubicin Synergistically Inhibits Dox-resistant Breast Cancer Progression via Down-regulation of Snail Through Suppressing Notch/NF-κB and RAS/RAF/MEK/ERK Signaling Pathway. Elsevier, 2021.

Warning: These citations may not always be 100% accurate.